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Accumulating evidence attests to a prosurvival role for autophagy 
under stress, by facilitating removal of 
damaged proteins and organelles and 
recycling basic building blocks, which 
can be utilized for energy generation 
and targeted macromolecular synthe-
sis to shore up cellular defenses. These 
observations are difficult to reconcile 
with the dichotomous prosurvival and 
death-inducing roles ascribed to macro-
autophagy in cardiac ischemia and 
reperfusion injury, respectively. A care-
ful reexamination of ‘flux’ through the 
macroautophagy pathway reveals that 
autophagosome clearance is markedly 
impaired with reperfusion (reoxygen-
ation) in cardiomyocytes following an 
ischemic (hypoxic) insult, resulting from 
reactive oxygen species (ROS)-mediated 
decline in LAMP2 and increase in 
BECN1 abundance. This results in 
impaired autophagy that is ‘ineffective’ 
in protecting against cell death with 
ischemia-reperfusion injury. Restoration 
of autophagosome clearance and by 
inference, ‘adequate’ autophagy, attenu-
ates reoxygenation-induced cell death.
Myocardial infarction most commonly 
results from thrombotic occlusion of a 
coronary artery resulting in ischemia; 
and spontaneous or therapeutic reperfu-
sion offers the best hope for myocardial 
salvage. However, reperfusion is accompa-
nied by a burst of ROS generation and fur-
ther injury, causing cardiomyocyte death 
and myocardial dysfunction. Despite 
significant research efforts, therapeutic 
options for reperfusion injury are limited 
to preventive pre-administration of phar-
macological agents, which is impractical 
in the clinical setting. Understanding the 
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role of autophagy in cardiomyocyte death 
in myocardial infarction, therefore, holds 
tremendous promise in development of 
strategies to promote myocardial salvage. 
Contemporaneous studies have employed 
autophagosome abundance as a readout 
for autophagy, and conclude that induc-
tion of autophagy via activation of ade-
nosine monophosphate-activated kinase 
(AMPK) is beneficial during the ischemic 
phase, but further activation of autophagy, 
i.e. an increase in autophagosome preva-
lence, by BECN1 upregulation causes cell 
death during reperfusion, thus present-
ing a conundrum in the development of a 
therapeutic approach targeting autophagy 
in ischemia-reperfusion injury.
Since ‘autophagy’ is a process, and 
assessment of its efficiency should ideally 
require assessment of the rate of degra-
dation of its substrates (such as damaged 
proteins and organelles) and/or the rate 
of generation of the end products (amino 
acids, sugars and lipids recycled back into 
the cytosol from the lysosomes), reliance 
on the levels of a single intermediate, such 
as autophagosomes, may not yield accurate 
conclusions. To overcome the limitation of 
the lack of a suitable single assay to track 
the efficiency of macroautophagy, we have 
employed complementary approaches 
to assess the autophagy process, namely 
autophagosome abundance in the pres-
ence or absence of an inhibitor of lyso-
somal acidification to assess ‘flux’; relative 
abundance of autophagosomes and autol-
ysosomes; relative levels of SQSTM1/p62, 
an adaptor protein that gets consumed 
during autophagy; and the clearance of 
polyglutamine aggregates that are pro-
cessed through macroautophagy. Our 
results indicate that autophagosome clear-
ance may be partially impaired during 
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which stimulates its own transcription) at 
72 h. Interestingly, exogenous expression 
of BECN1 to supranormal levels transcrip-
tionally downregulates these genes (except 
for Sqstm1); and taken together these 
observations point to a critical role for 
BECN1 protein abundance in regulating 
a transcriptional network that responds 
to activation of autophagy to prime the 
machinery for its successful and con-
tinued ‘adequate’ execution. Unraveling 
the details of this network is the focus of 
ongoing studies. Based on these data, we 
posit that reperfusion-induced ROS stabi-
lizes BECN1 protein resulting in increased 
BECN1 abundance, which transcription-
ally suppresses the autophagy-lysosome 
machinery and paradoxically causes an 
impairment in autophagosome process-
ing, with resultant accumulation of auto-
phagosomes (and undegraded cargo) and 
cell death. Partial knockdown of BECN1 
in this setting relieves the transcriptional 
inhibition of the autophagy-lysosome 
machinery, enhancing autophagic flux, 
whereas adequate BECN1 protein is 
available for its obligate role in auto-
phagosome formation. It is conceivable 
reoxygenation, which are dependent on 
the degree of knockdown in hypoxia-reox-
ygenation-treated cardiomyocytes. Partial 
Becn1 knockdown results in restoration of 
relative predominance of autolysosomes, 
suggesting restored autophagosome pro-
cessing; whereas a more complete knock-
down prevents autophagosome formation. 
Importantly, partial Becn1 knockdown 
also prevents reoxygenation-induced car-
diomyocte death, mirroring previous 
observations of reduced infarct size in 
Becn1 haplo-insufficient mice subjected to 
ischemia-reperfusion injury, in vivo; and a 
more complete Becn1 knockdown impairs 
autophagosome formation and increases 
cell death, confirming a critical prosur-
vival role for autophagy in this setting.
Furthermore, our data suggest that 
BECN1 levels transcriptionally regulate 
components of the autophagy-lysosome 
machinery such that Becn1 knockdown 
results in early (within 48 h) transcrip-
tional upregulation of candidate genes as 
Map1lc3b, Sqstm1, Rab7 and Lamp1 with 
buildup of the respective protein levels, 
followed by transcriptional downregula-
tion (except for the Sqstm1 transcript, 
ischemia and is severely impaired during 
reperfusion, resulting in accumulation of 
autophagosomes, and presumably undi-
gested cargo, which manifests in further 
ROS generation, mitochondrial permeabi-
lization and a necrotic mechanism of cell 
death (Fig. 1). Importantly, restoring auto-
phagosome processing and reestablishing 
adequate flux through macroautophagy 
attenuates reoxygenation-induced cardio-
myocyte death.
The mechanism for the impairment 
in autophagosome processing appears 
two-fold. Both ischemia and reperfusion 
induce a decline in levels of LAMP2, a 
lysosome membrane protein that plays 
an important role in autophagosome-
lysosome fusion, which is driven by ROS 
generation with reperfusion. Accordingly, 
exogenous expression of either the 
LAMP2A or LAMP2B isoform results in 
restoration of autophagosome processing 
in cardiomyocytes subjected to hypoxia-
reoxygenation. Additionally, reperfusion 
induces a ROS-driven increase in BECN1 
abundance. However, shRNA mediated 
knockdown of Becn1 transcripts reveals 
surprising and dichotomous outcomes with 
Figure 1. Schematic depicting the proposed outcomes of autophagy in myocardial ischemia-reperfusion injury. Autophagosome formation is induced 
by ischemia (hypoxia) via AmpK activation, and further stimulated by reperfusion (reoxygenation) secondary to RoS-induced cellular injury. previous 
work suggests a critical prosurvival role for autophagy in ischemia, by ensuring nutrient supply. our data demonstrate that both ischemia and reperfu-
sion lead to a decline in LAmp2, which is important for autophagosome-lysosome fusion. Reperfusion-induced RoS also provokes increased BEcn1 
abundance, which stimulates autophagosome formation, but results in transcriptional inhibition of the autophagy-lysosome machinery. together, 
these provoke marked impairment of autophagosome clearance with resultant autophagosome accumulation, and impaired removal of damaged 
cellular constituents. this sets up a vicious cycle of increased RoS generation and mitochondrial permeabilization, culminating in necrotic cell death, 
which can be attenuated by cyclosporin A (csA), an inhibitor of mitochondrial permeability transition pore. ‘?’ indicates undefined mechanisms.
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and in vitro, which will facilitate accurate 
conclusions regarding its role in health 
and disease.
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stages, i.e., after the formation of auto-
phagosomes, in cardiac ischemia-reper-
fusion injury, which renders autophagy 
‘inadequate’ in preventing cardiomyo-
cyte death. The results also underscore 
the need to carefully evaluate the effi-
ciency of the ‘process’ of autophagy with 
multiple readouts at various steps, spread 
out temporally, to prevent erroneous 
conclusions. Importantly, there remains 
an acute need for development of better 
assays to assess autophagic flux in vivo 
that other potential outcomes of increased 
BECN1 levels, such as interaction with 
KIAA0226/rubicon to inhibit auto-
phagosome processing, pro-apoptogenic 
caspase-mediated cleavage, modulation of 
deubiquitinating enzymes and TP53/p53, 
and other hitherto undiscovered mecha-
nisms contribute to its deleterious role in 
reperfusion-induced cell death, and will 
require further investigation.
In summary, our data demonstrate 
that autophagy is impaired at the late 
